parC mutations in fluoroquinolone-resistant Borrelia burgdorferi

  • Kendal M. Galbraith
  • , Amanda C. Ng
  • , Betsy J. Eggers
  • , Craig R. Kuchel
  • , Christian H. Eggers
  • , D. Scott Samuels

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

We have isolated in vitro fluoroquinolone-resistant mutants of the Lyme disease agent, Borrelia burgdorferi. Mutations in parC, which encodes a subunit of topoisomerase IV, were associated with loss of susceptibility to sparfloxacin, moxifloxacin, and Bay-Y3118, but not ciprofloxacin. This is the first description of fluoroquinolone resistance in the spirochete phylum.

Original languageEnglish
Pages (from-to)4354-4357
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume49
Issue number10
DOIs
StatePublished - Oct 2005

Funding

Funder number
R01AI051486

    Fingerprint

    Dive into the research topics of 'parC mutations in fluoroquinolone-resistant Borrelia burgdorferi'. Together they form a unique fingerprint.

    Cite this